Dopamine News and Research

Latest Dopamine News and Research

Modified lipids target the body’s endocannabinoid system to regulate pain and inflammation

When modified using a process known as epoxidation, two naturally occurring lipids are converted into potent agents that target multiple cannabinoid receptors in neurons, interrupting pathways that promote pain and inflammation, researchers report.

10 Feb 2021

New combination treatment approach improves overall survival in mice with glioblastoma

In a study of mice, researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new approach that combines an anti-psychotic drug, a statin used to lower high cholesterol levels, and radiation to improve the overall survival in mice with glioblastoma.

9 Feb 2021

Imaging technique can differentiate Alzheimer's disease from dementia with Lewy bodies

Scientists in Portugal and the United Kingdom were able to confirm that an imaging technique that traces neuronal dopaminergic deficiency in the brain is able to differentiate, in vivo, Alzheimer's disease from lesser-known dementia with Lewy bodies.

5 Feb 2021

Spontaneous eye blink rate could help understand the link between fitness and cognitive function

Although exercise is known to enhance cognitive function and improve mental health, the neurological mechanisms of this link are unknown. Now, researchers from Japan have found evidence of the missing link between aerobic fitness and cognitive function.

4 Feb 2021

Scientists unravel the workings of a mysterious protein implicated in movement disorders

Scientists at Scripps Research have clarified the workings of a mysterious protein called Gαo, which is one of the most abundant proteins in the brain and, when mutated, causes severe movement disorders.

3 Feb 2021

Scientists discover mechanism for transient memory lapse

In a landmark neurobiology study, scientists from Scripps Research have discovered a memory gating system that employs the neurotransmitter dopamine to direct transient forgetting, a temporary lapse of memory which spontaneously returns.

21 Jan 2021

BMP5/7 protein offers promising therapeutics that could halt the progression of Parkinson's disease

Ben-Gurion University of the Negev researchers have discovered that the protein BMP5/7 offers promising therapeutics that could slow down or halt the progression of Parkinson's disease.

20 Jan 2021

Simple vision tests can predict Parkinson's dementia before it begins

Simple vision tests can predict which people with Parkinson's disease will develop cognitive impairment and possible dementia 18 months later, according to a new study by UCL researchers.

19 Jan 2021

Researchers find potential biomarkers of Parkinson's disease

A research team led by Nagoya University in Japan has found that blood pressure, the hematocrit (the percentage of red blood cells in blood), and serum cholesterol levels change in patients with Parkinson's disease long before the onset of motor symptoms.

18 Jan 2021

Patients with schizophrenia have increased risk of Parkinson's disease, shows study

A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life.

15 Jan 2021

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown.

7 Jan 2021

Repeated ketamine infusions may be a promising treatment for PTSD patients

Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a study conducted by researchers from the Icahn School of Medicine at Mount Sinai.

5 Jan 2021

Neuroscientists track gene expression to gain insights into drug addiction, Parkinson's disease

Two MIT neuroscientists have received grants from the G. Harold and Leila Y. Mathers Foundation to screen for genes that could help brain cells withstand Parkinson's disease and to map how gene expression changes in the brain in response to drugs of abuse.

4 Jan 2021

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

The School of Medicine at the University of California, Riverside, will serve as lead site for a Phase 2 clinical trial evaluating ecopipam, an investigational first-in-class drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients.

15 Dec 2020

Dopamine News and Research

Latest Dopamine News and Research

Modified lipids target the body’s endocannabinoid system to regulate pain and inflammation

New combination treatment approach improves overall survival in mice with glioblastoma

Imaging technique can differentiate Alzheimer's disease from dementia with Lewy bodies

Spontaneous eye blink rate could help understand the link between fitness and cognitive function

Scientists unravel the workings of a mysterious protein implicated in movement disorders

Scientists discover mechanism for transient memory lapse

BMP5/7 protein offers promising therapeutics that could halt the progression of Parkinson's disease

Simple vision tests can predict Parkinson's dementia before it begins

Researchers find potential biomarkers of Parkinson's disease

Patients with schizophrenia have increased risk of Parkinson's disease, shows study

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Repeated ketamine infusions may be a promising treatment for PTSD patients

Neuroscientists track gene expression to gain insights into drug addiction, Parkinson's disease

Phase 2 clinical trial at UCR to test first-in-class drug for treatment of stuttering

Economic activity can actively change the brain, shows study

Tomatoes could become a new, natural source of Parkinson's disease drug

Researchers identify potential drug target that may improve cognition in people with mental illnesses

Normal sleep depends on bacteria in the gut

Anti-diabetic drug could be repurposed for treating Parkinson's disease

Dopamine-release mechanisms in the brain may play a major role in SARS-CoV-2 infection

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Dopamine News and Research

Latest Dopamine News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in